LMR Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-2,023,659
Closed -$79.6M – 1121
2023
Q2
$79.6M Buy
+2,023,659
New +$71.4M 0.88% 15
2017
Q3
– Sell
-104,958
Closed -$269K – 593
2017
Q2
$269K Buy
+104,958
New +$286K 0.02% 491

LMR Partners's ISEE Position: Q3 2023 in Review

LMR Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 2,023,659 shares — an estimated $79.6M sold.

LMR Partners first reported a position in ISEE in Q2 2017 and held it in 2 quarters. The position peaked at $79.6M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • LMR Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • LMR Partners sold 2,023,659 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $79.6M.
  • LMR Partners first reported a position in IVERIC bio, Inc. Common Stock in Q2 2017 and held it in 2 quarters.
  • LMR Partners's IVERIC bio, Inc. Common Stock position peaked at $79.6M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on LMR Partners's 13F filing for Q3 2023, filed 14 Nov 2023.